Nuprin Backache Interactions
There are 286 drugs known to interact with Nuprin Backache (magnesium salicylate), along with 9 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 16 are major, 235 are moderate, and 35 are minor.
- View all 286 medications that may interact with Nuprin Backache
- View Nuprin Backache alcohol/food interactions (1)
- View Nuprin Backache disease interactions (9)
Most frequently checked interactions
View interaction reports for Nuprin Backache (magnesium salicylate) and the medicines listed below.
- acarbose
- acetylcysteine
- alfuzosin
- amiodarone
- amlodipine
- aripiprazole
- Aromasin (exemestane)
- atovaquone
- atovaquone / proguanil
- Aubagio (teriflunomide)
- azelastine nasal
- Azilect (rasagiline)
- Bactroban (mupirocin topical)
- benztropine
- budesonide nasal
- candesartan
- carbamazepine
- carbidopa / levodopa
- carisoprodol
- carvedilol
- cefpodoxime
- cefuroxime
- celecoxib
- cilostazol
- ciprofloxacin
- Claravis (isotretinoin)
- donepezil
- doxazosin
- doxepin
- rosuvastatin
Nuprin Backache alcohol/food interactions
There is 1 alcohol/food interaction with Nuprin Backache (magnesium salicylate).
Nuprin Backache disease interactions
There are 9 disease interactions with Nuprin Backache (magnesium salicylate) which include:
- GI toxicity
- renal dysfunction
- Reye's syndrome
- hypermagnesemia
- anemia
- coagulation
- dialysis
- G-6-PD deficiency
- hepatotoxicity
More about Nuprin Backache (magnesium salicylate)
- Nuprin Backache consumer information
- Check interactions
- Compare alternatives
- Side effects
- Drug class: salicylates
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.